Tolvaptan, an Oral Vasopressin V2 Receptor Antagonist for Heart Failure?

2007 ◽  
Vol 50 (6) ◽  
pp. 904-907
Author(s):  
Arthur Greenberg
Keyword(s):  
Heart Failure ◽  
Receptor Antagonist ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

Effect of SR121463, a Selective Non-Peptide Vasopressin V2 Receptor Antagonist, in a Rabbit Model of Ocular Hypertension

2000 ◽  
Vol 16 (3) ◽  
pp. 203-216 ◽  
Author(s):  
FREDERIC LACHERETZ ◽  
ALAIN BARBIER ◽  
CLAUDINE SERRADEIL-LE GAL ◽  
PIERRE-PAUL ELENA ◽  
JEAN-PIERRE MAFFRAND ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Ocular Hypertension ◽  
Rabbit Model ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

scholarly journals OPC-31260, a nonpeptide vasopressin V2 receptor antagonist is a novel aquaretic agent

1992 ◽  
Vol 58 ◽  
pp. 195
Author(s):  
Shigeki Nakamura ◽  
Yoshitaka Yamamura ◽  
Hidenori Ogawa ◽  
Tomihiko Chihara ◽  
Toshiyuki Onogawa ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist

scholarly journals FP051DETERMINANTS OF URINE VOLUME IN ADPKD-PATIENTS USING THE VASOPRESSIN V2 RECEPTOR ANTAGONIST TOLVAPTAN

2018 ◽  
Vol 33 (suppl_1) ◽  
pp. i64-i65
Author(s):  
Bart Kramers ◽  
Judith Heida ◽  
Wendy Boertien ◽  
Maatje van Gastel ◽  
Esther Meijer ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Urine Volume ◽  
Vasopressin V2 Receptor ◽  
V2 Receptor ◽  
Vasopressin V2 Receptor Antagonist ◽  
V2 Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document